DICLOFENAC SODIUM and PRODUCT USE ISSUE

9,001 reports of this reaction

1.6% of all DICLOFENAC SODIUM reports

#10 most reported adverse reaction

Overview

PRODUCT USE ISSUE is the #10 most commonly reported adverse reaction for DICLOFENAC SODIUM, manufactured by Haleon US Holdings LLC. There are 9,001 FDA adverse event reports linking DICLOFENAC SODIUM to PRODUCT USE ISSUE. This represents approximately 1.6% of all 574,671 adverse event reports for this drug.

Patients taking DICLOFENAC SODIUM who experience product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PRODUCT USE ISSUE9,001 of 574,671 reports

PRODUCT USE ISSUE is a less commonly reported adverse event for DICLOFENAC SODIUM, but still significant enough to appear in the safety profile.

Other Side Effects of DICLOFENAC SODIUM

In addition to product use issue, the following adverse reactions have been reported for DICLOFENAC SODIUM:

DRUG INEFFECTIVE — 29,162 reports
PAIN — 14,383 reports
FATIGUE — 12,871 reports
PRODUCT USE IN UNAPPROVED INDICATION — 12,852 reports
OFF LABEL USE — 12,645 reports
ARTHRALGIA — 10,222 reports
RASH — 10,134 reports
RHEUMATOID ARTHRITIS — 9,762 reports
ABDOMINAL DISCOMFORT — 9,017 reports
NAUSEA — 8,465 reports

Other Drugs Associated with PRODUCT USE ISSUE

The following drugs have also been linked to product use issue in FDA adverse event reports:

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE ALUMINUM HYDROXIDE ARFORMOTEROL TARTRATE ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE BAYER GENUINE ASPIRIN BREXPIPRAZOLE BRIVARACETAM BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE BUTENAFINE HYDROCHLORIDE CAMPHOR AND MENTHOL CAMPHOR, EUCALYPTUS OIL, MENTHOL CAMPHOR (SYNTHETIC), EUCALYPTUS OIL, AND MENTHOL CRISABOROLE DEUTETRABENAZINE ESMOLOL HYDROCHLORIDE FLUMAZENIL

Frequently Asked Questions

Does DICLOFENAC SODIUM cause PRODUCT USE ISSUE?

PRODUCT USE ISSUE has been reported as an adverse event in 9,001 FDA reports for DICLOFENAC SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PRODUCT USE ISSUE with DICLOFENAC SODIUM?

PRODUCT USE ISSUE accounts for approximately 1.6% of all adverse event reports for DICLOFENAC SODIUM, making it a notable side effect.

What should I do if I experience PRODUCT USE ISSUE while taking DICLOFENAC SODIUM?

If you experience product use issue while taking DICLOFENAC SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

DICLOFENAC SODIUM Full Profile All Drugs Causing PRODUCT USE ISSUE Haleon US Holdings LLC Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.